These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18167425)

  • 21. Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder.
    Goodwin FK
    J Clin Psychiatry; 2003; 64 Suppl 5():18-24. PubMed ID: 12720480
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute and maintenance treatment of bipolar mania: the role of atypical antipsychotics.
    Yatham LN
    Bipolar Disord; 2003; 5 Suppl 2():7-19. PubMed ID: 14700009
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Olanzapine: a review of its use in the management of bipolar I disorder.
    McCormack PL; Wiseman LR
    Drugs; 2004; 64(23):2709-26. PubMed ID: 15537371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Olanzapine-divalproex combination versus divalproex monotherapy in the treatment of bipolar mixed episodes: a double-blind, placebo-controlled study.
    Houston JP; Tohen M; Degenhardt EK; Jamal HH; Liu LL; Ketter TA
    J Clin Psychiatry; 2009 Nov; 70(11):1540-7. PubMed ID: 19778495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.
    Owen RT
    Drugs Today (Barc); 2006 Mar; 42(3):185-92. PubMed ID: 16628260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Atypical antipsychotics in bipolar depression: potential mechanisms of action.
    Yatham LN; Goldstein JM; Vieta E; Bowden CL; Grunze H; Post RM; Suppes T; Calabrese JR
    J Clin Psychiatry; 2005; 66 Suppl 5():40-8. PubMed ID: 16038601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
    Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newer treatment studies for bipolar depression.
    Gao K; Calabrese JR
    Bipolar Disord; 2005; 7 Suppl 5():13-23. PubMed ID: 16225556
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mood stabilizer augmentation with olanzapine in acutely manic children.
    Chang KD; Ketter TA
    J Child Adolesc Psychopharmacol; 2000; 10(1):45-9. PubMed ID: 10755582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.
    Tohen M; Greil W; Calabrese JR; Sachs GS; Yatham LN; Oerlinghausen BM; Koukopoulos A; Cassano GB; Grunze H; Licht RW; Dell'Osso L; Evans AR; Risser R; Baker RW; Crane H; Dossenbach MR; Bowden CL
    Am J Psychiatry; 2005 Jul; 162(7):1281-90. PubMed ID: 15994710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atypical antipsychotics for bipolar disorder.
    Yatham LN
    Psychiatr Clin North Am; 2005 Jun; 28(2):325-47. PubMed ID: 15826735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rapid and systematic review and economic evaluation of the clinical and cost-effectiveness of newer drugs for treatment of mania associated with bipolar affective disorder.
    Bridle C; Palmer S; Bagnall AM; Darba J; Duffy S; Sculpher M; Riemsma R
    Health Technol Assess; 2004 May; 8(19):iii-iv, 1-187. PubMed ID: 15147609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial.
    Yatham LN; Beaulieu S; Schaffer A; Kauer-Sant'Anna M; Kapczinski F; Lafer B; Sharma V; Parikh SV; Daigneault A; Qian H; Bond DJ; Silverstone PH; Walji N; Milev R; Baruch P; da Cunha A; Quevedo J; Dias R; Kunz M; Young LT; Lam RW; Wong H
    Mol Psychiatry; 2016 Aug; 21(8):1050-6. PubMed ID: 26460229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative efficacy of typical and atypical antipsychotics as add-on therapy to mood stabilizers in the treatment of acute mania.
    Miller DS; Yatham LN; Lam RW
    J Clin Psychiatry; 2001 Dec; 62(12):975-80. PubMed ID: 11780879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
    Grunze H; Dittmann S
    MMW Fortschr Med; 2003 May; 145 Suppl 2():27-30. PubMed ID: 14579481
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis.
    Taylor DM; Cornelius V; Smith L; Young AH
    Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life assessment in patients with bipolar disorder treated with olanzapine added to lithium or valproic acid.
    Namjoshi MA; Risser R; Shi L; Tohen M; Breier A
    J Affect Disord; 2004 Sep; 81(3):223-9. PubMed ID: 15337326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance therapies in bipolar disorder: focus on randomized controlled trials.
    Muzina DJ; Calabrese JR
    Aust N Z J Psychiatry; 2005 Aug; 39(8):652-61. PubMed ID: 16050919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aripiprazole alone or in combination for acute mania.
    Brown R; Taylor MJ; Geddes J
    Cochrane Database Syst Rev; 2013 Dec; (12):CD005000. PubMed ID: 24346956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.